Xcout IntelCrossbow Therapeutics, Inc.
Crossbow Therapeutics is a privately held biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts. The company develops potent antibody therapeutics aimed at expanding treatment options and combating cancer.
Subscribe to see Crossbow Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Crossbow Therapeutics, Inc. at a glance
Crossbow Therapeutics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series B, raised $77M in March 2026. Xcout tracks 10 named people at Crossbow Therapeutics, Inc., including Briggs Morrison (Chief Executive Officer). Xcout recorded 1 job posting from Crossbow Therapeutics, Inc. in the last 90 days.
Crossbow Therapeutics, Inc. leadership
- Briggs MorrisonChief Executive Officer
- Alexander NolteExecutive Officer
- Briggs MorrisonExecutive Officer
- Dmitri WiederschainExecutive Officer
- Alexandra CantleyDirector
- Alon LazarusDirector
4 more named people on record for Crossbow Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Crossbow Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $77M | 9 named | |
| SEC Form D filing | $30.3M | — | |
| SEC Form D filing | $37.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Crossbow Therapeutics, Inc.
Xcout recorded 1 job posting from Crossbow Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Crossbow Therapeutics, Inc.'s hiring signals →
Investors
Crossbow Therapeutics, Inc. competitors
A few of Crossbow Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
CrossBridge Bio, Inc. is a medical technology and biopharmaceutical company pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADCs).
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Matrisome Bio is a biotechnology startup headquartered in Cambridge, Massachusetts, focused on transforming cancer therapy by delivering potent payloads directly to the extracellular matrix of tumors and metastases.
Proximity Therapeutics, Inc. is a privately held biopharmaceutical and biotechnology company based in Cambridge, Massachusetts, founded in 2021. The neuro space company operates as a provider of biotechnology and develops next-generation medicines by controlling biological processes through proximity.
Get Crossbow Therapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Crossbow Therapeutics, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access